Basilea Pharmaceutica Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Basilea Pharmaceutica Limited with three other
miscellaneous service companies in Europe:
sales of 36.94 million Euro [US$39.17 million]
of which 100%
was Regenerative Medicine),
(332.04 million Norwegian Kroner [US$38.92 million]
based in France
(56.39 million Euro [US$59.79 million]
of which 101%
Basilea Pharmaceutica Limited reported sales of 51.65 million Swiss Francs (US$51.04 million)
December of 2015.
increase of 21.5%
versus 2014, when the company's sales were 42.50 million Swiss Francs.